{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:41:10Z","timestamp":1785361270578,"version":"3.55.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Hepcidin, a short peptide synthesized primarily by hepatocytes in response to increased body iron and inflammation, is a crucial iron-regulating factor. Hepcidin regulates intestinal iron absorption and releases iron from macrophages into plasma through a negative iron feedback mechanism. The discovery of hepcidin inspired a torrent of research into iron metabolism and related problems, which have radically altered our understanding of human diseases caused by an excess of iron, an iron deficiency, or an iron disparity. It is critical to decipher how tumor cells manage hepcidin expression for their metabolic requirements because iron is necessary for cell survival, particularly for highly active cells like tumor cells. Studies show that tumor and non-tumor cells express and control hepcidin differently. These variations should be explored to produce potential novel cancer treatments. The ability to regulate hepcidin expression to deprive cancer cells of iron may be a new weapon against cancer cells.<\/jats:p>","DOI":"10.3389\/fonc.2023.1141603","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T06:11:46Z","timestamp":1676959906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Distinctive modulation of hepcidin in cancer and its therapeutic relevance"],"prefix":"10.3389","volume":"13","author":[{"given":"Feng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Tuffour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Addai","family":"Peprah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26001","article-title":"Cell-type-specific insights into iron regulatory processes","volume":"96","author":"Mleczko-Sanecka","year":"2021","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2018.00103","article-title":"Inherited disorders of iron overload","volume":"5","author":"Pantopoulos","year":"2018","journal-title":"Front Nutr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ph12030129","article-title":"The antitumor didox acts as an iron chelator in hepatocellular carcinoma cells","volume":"12","author":"Asperti","year":"2019","journal-title":"Pharmaceuticals"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/thno.59092","article-title":"Targeting iron metabolism in cancer therapy","volume":"11","author":"Morales","year":"2021","journal-title":"Theranostics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAMCR.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/S41586-020-2668-Z","article-title":"Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms","volume":"586","author":"Billesb\u00f8lle","year":"2020","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/BJH.17252","article-title":"Physiological and pathophysiological mechanisms of hepcidin regulation: Clinical implications for iron disorders","volume":"193","author":"Xu","year":"2021","journal-title":"Br J Haematology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12998\/WJCC.V7.I15.1926","article-title":"Extrahepatic hepcidin production: The intriguing outcomes of recent years","volume":"7","author":"Daher","year":"2019","journal-title":"World J Clin cases"},{"key":"B10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/J.ACKD.2019.04.005","article-title":"Hepcidin","volume":"26","author":"Agarwal","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B11","article-title":"Hepcidin\u2013the iron regulatory hormone","volume":"26","author":"Rossi","year":"2005","journal-title":"Clin Biochemist Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1038\/EMM.2017.273","article-title":"Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications","volume":"50","author":"Vela","year":"2018","journal-title":"Exp Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/J.HOC.2017.11.009","article-title":"Ineffective erythropoiesis: anemia and iron overload","volume":"32","author":"Gupta","year":"2018","journal-title":"Hematology\/Oncology Clinics North America"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr1121","article-title":"Mellor j. a pre-initiation complex at the 3'-end of genes drives antisense transcription independent of divergent sense transcription","volume":"40","author":"Murray","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications","volume":"113","author":"Theurl","year":"2009","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/NG.130","article-title":"Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)","volume":"40","author":"Finberg","year":"2008","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/KI.2009.357","article-title":"Iron-refractory iron deficiency anemia: New molecular mechanisms","volume":"76","author":"Cui","year":"2009","journal-title":"Kidney Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/J.HEMONC.2020.04.007","article-title":"Genetic analysis of TMPRSS6 gene in Saudi female patients with iron deficiency anemia","volume":"14","author":"Al-Jamea","year":"2021","journal-title":"Hematology\/Oncology Stem Cell Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/S10020-018-0008-7","article-title":"Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker","volume":"24","author":"Vela","year":"2018","journal-title":"Mol Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13817","article-title":"Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of akt","volume":"7","author":"Han","year":"2016","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-1123","article-title":"Iron-deficiency anemia in castleman disease: Implication of the interleukin 6\/hepcidin pathway","volume":"126","author":"Arlet","year":"2010","journal-title":"Pediatrics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2010-03-271791","article-title":"Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric castleman disease","volume":"116","author":"Song","year":"2010","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01753-2","article-title":"Hepcidin in hepatocellular carcinoma","volume":"127","author":"Joachim","year":"2022","journal-title":"Br J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.893149","article-title":"Effects of exogenous transferrin on the regulation of iron metabolism and erythropoiesis in iron deficiency with or without anemia","volume":"13","author":"Li","year":"2022","journal-title":"Front Physiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115495","article-title":"Bone morphogenic proteins in iron homeostasis","volume":"138","author":"Xiao","year":"2020","journal-title":"Bone"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-721571","article-title":"Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice","volume":"129","author":"Canali","year":"2017","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2016-12-754499","article-title":"Liver sinusoidal endothelial cells as iron sensors","volume":"129","author":"Parrow","year":"2017","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197148","article-title":"Orphan nuclear receptor ERRgamma is a novel transcriptional regulator of IL-6 mediated hepatic BMP6 gene expression in mice","volume":"21","author":"Radhakrishnan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/BS.VH.2019.01.003","article-title":"Signaling pathways regulating hepcidin","volume":"110","author":"Rishi","year":"2019","journal-title":"Vitamins Hormones"},{"key":"B30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/TGH.2019.11.15","article-title":"Inherited iron overload disorders","volume":"5","author":"Piperno","year":"2020","journal-title":"Trans Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/J.BCMD.2018.10.006","article-title":"Variable expressivity of HJV related hemochromatosis: \"Juvenile\" hemochromatosis","volume":"74","author":"Hamdi-Roz\u00e9","year":"2019","journal-title":"Blood Cells Molecules Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3945\/AJCN.117.155804","article-title":"Current understanding of iron homeostasis","volume":"106","author":"Anderson","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1039\/C7MT00143F","article-title":"The transferrin receptor: The cellular iron gate","volume":"9","author":"Gammella","year":"2017","journal-title":"Metallomics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2018-05-850404","article-title":"Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load","volume":"133","author":"Fillebeen","year":"2019","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e77267","DOI":"10.1371\/JOURNAL.PONE.0077267","article-title":"In situ proximity ligation assays indicate that hemochromatosis proteins hfe and transferrin receptor 2 (Tfr2) do not interact","volume":"8","author":"Rishi","year":"2013","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/NG.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/NG.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.044","article-title":"BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in hfe knockout mice","volume":"139","author":"Corradini","year":"2010","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/S41588-019-0548-Y","article-title":"Author correction: Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"52","author":"Kautz","year":"2020","journal-title":"Nat Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2017-04-777987","article-title":"Immunoassay for human serum erythroferrone","volume":"130","author":"Ganz","year":"2017","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.19746\/j.cnki.issn.1009-2137.2021.01.034","article-title":"Hepcidin and erythroferrone levels in child-bearing women with iron deficiency anemia","volume":"29","author":"Xu","year":"2021","journal-title":"Zhongguo Shi Yan xue Ye Xue Za Zhi"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/EJH.13021","article-title":"Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia","volume":"100","author":"El Gendy","year":"2018","journal-title":"Eur J Haematology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000494","article-title":"New insights into the links between hypoxia and iron homeostasis","volume":"26","author":"Renassia","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/EJH.13062","article-title":"Hepcidin regulation in a mouse model of acute hypoxia","volume":"100","author":"Ravasi","year":"2018","journal-title":"Eur J Haematology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01315-X","article-title":"Haemochromatosis","volume":"388","author":"Powell","year":"2016","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/andr.12622","article-title":"Hepcidin is not essential for mediating testosterone's effects on erythropoiesis","volume":"8","author":"Guo","year":"2020","journal-title":"Andrology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e40465","DOI":"10.1371\/JOURNAL.PONE.0040465","article-title":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes","volume":"7","author":"Ikeda","year":"2012","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI83831","article-title":"Progesterone receptor membrane component-1 regulates hepcidin biosynthesis","volume":"126","author":"Li","year":"2016","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.25615","article-title":"Inhibition of hepcidin transcription by growth factors","volume":"56","author":"Goodnough","year":"2012","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.vh.2019.01.004","article-title":"Hepcidin and the BMP-SMAD pathway: An unexpected liaison","volume":"110","author":"Silvestri","year":"2019","journal-title":"Vitamin hormones"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.0409808102","article-title":"Regulation of hepcidin transcription by interleukin-1 and interleukin-6","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The nuclear factor kappa b (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/HEP4.1717","article-title":"Hepcidin signaling in health and disease: ironing out the details","volume":"5","author":"Kowdley","year":"2021","journal-title":"Hepatol Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2007-07-100677","article-title":"Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis","volume":"111","author":"Silvestri","year":"2008","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"43ra56","DOI":"10.1126\/SCISIGNAL.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci Trans Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/J.CBI.2020.109021","article-title":"Iron and hepcidin mediate human colorectal cancer cell growth","volume":"319","author":"Sornjai","year":"2020","journal-title":"Chemico-Biological Interact"},{"key":"B57","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-018-1001-3","article-title":"E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell Death Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2015.140772","article-title":"Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels","volume":"101","author":"Kovac","year":"2016","journal-title":"Haematologica"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-10-36","article-title":"Expression of iron-related genes in human brain and brain tumors","volume":"10","author":"H\u00e4nninen","year":"2009","journal-title":"BMC Neurosci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.714756","article-title":"Hepcidin downregulation correlates with disease aggressiveness and immune infiltration in liver cancers","volume":"11","author":"Wang","year":"2021","journal-title":"Frontier Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/SJ.ONC.1210711","article-title":"A role for iron in wnt signalling","volume":"27","author":"Brookes","year":"2008","journal-title":"Oncogene"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M210905200","article-title":"Signaling role of intracellular iron in NF-\u03bab activation","volume":"278","author":"Xiong","year":"2003","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3748\/WJG.V16.I6.663","article-title":"Iron: An emerging factor in colorectal carcinogenesis","volume":"16","author":"Chua","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/S42255-021-00406-7","article-title":"Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells","volume":"3","author":"Schwartz","year":"2021","journal-title":"Nat Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.778492","article-title":"The role of iron in cancer progression","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102837","article-title":"Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia","volume":"145","author":"Abdel-Razeq","year":"2020","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2017","article-title":"Iron and cancer: 2020 vision","volume":"80","author":"Torti","year":"2020","journal-title":"Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3892\/OL.2018.8544","article-title":"Role of hepcidin and iron metabolism in the onset of prostate cancer","volume":"15","author":"Zhao","year":"2018","journal-title":"Oncol Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105773","article-title":"Circulating osteocyte-related biomarkers (vitamin d, sclerostin, dickkopf-1), hepcidin, and oxidative stress markers in early breast cancer: Their impact in disease progression and outcome","volume":"204","author":"El-Mahdy","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16208","article-title":"Iron and liver cancer: An inseparable connection","volume":"289","author":"Hino","year":"2022","journal-title":"FEBS J"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00527-1","article-title":"Hepatocellular carcinoma: Old friends and new tricks","volume":"52","author":"Kim","year":"2020","journal-title":"Exp Mol Medicin"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126493","article-title":"Hepcidin-ferroportin interaction controls systemic iron homeostasis","volume":"22","author":"Nemeth","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e00192","DOI":"10.1042\/BSR20150014","article-title":"Hepcidin: Regulation of the master iron regulator","volume":"35","author":"Rishi","year":"2015","journal-title":"Bioscience Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603124103","article-title":"Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of hfe, transferrin receptor 2 (Tfr2), and IL-6","volume":"103","author":"Truksa","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.123","article-title":"Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma","volume":"91","author":"Maegdefrau","year":"2011","journal-title":"Lab Invest"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/path.2563","article-title":"Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression","volume":"218","author":"Maegdefrau","year":"2009","journal-title":"J Pathol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"HEP18","DOI":"10.2217\/hep-2020-0001","article-title":"JAK\/STAT signaling in hepatocellular carcinoma","volume":"7","author":"Hin Tang","year":"2020","journal-title":"Hepat Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e12870","DOI":"10.1111\/eci.12870","article-title":"Hepcidin and DNA promoter methylation in hepatocellular carcinoma","volume":"48","author":"Udali","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-167","article-title":"Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma","volume":"8","author":"Kijima","year":"2008","journal-title":"BMC Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9020048","article-title":"HAMP downregulation contributes to aggressive hepatocellular carcinoma via mechanism mediated by Cyclin4-dependent kinase-1\/STAT3 pathway","volume":"9","author":"Shen","year":"2019","journal-title":"Diagnostics"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0243-y","article-title":"Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer","volume":"37","author":"Blanchette-Farra","year":"2018","journal-title":"Oncogene 2018 37:29"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELLSIG.2014.07.029","article-title":"Disordered hepcidin-ferroportin signaling promotes breast cancer growth","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell Signalling"},{"key":"B84","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/2277-9175.184298","article-title":"Evaluation of prostatic cancer prevalence in patients with prostatic-specific antigen between 4 and 10 and normal digital rectal examination","volume":"5","author":"Tadayon","year":"2016","journal-title":"Advanced Biomed Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2465","article-title":"Hepcidin regulation in prostate and its disruption in prostate cancer","volume":"75","author":"Tesfay","year":"2015","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"De Berardinis","year":"2016","journal-title":"Sci Adv"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.0700735104","article-title":"JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer","volume":"104","author":"Xiang","year":"2007","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/01635580701308265","article-title":"Iron stimulates urokinase plasminogen activator expression and activates NF-kappa b in human prostate cancer cells","volume":"58","author":"Ornstein","year":"2007","journal-title":"Nutr Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/J.REDOX.2017.08.015","article-title":"Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis","volume":"14","author":"Masaldan","year":"2018","journal-title":"Redox Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21124507","article-title":"The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling","volume":"21","author":"Shorning","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/CAAC.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: A Cancer J Clin"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31871","article-title":"Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas","volume":"117","author":"Gao","year":"2007","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2388","article-title":"IL6 trans-signaling promotes KRAS-driven lung carcinogenesis","volume":"76","author":"Brooks","year":"2016","journal-title":"Cancer Res"},{"key":"B94","first-page":"195","article-title":"Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer","volume":"13","author":"Yildirim","year":"2007","journal-title":"Med Sci Monitor"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/J.CANLET.2016.08.006","article-title":"EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1","volume":"381","author":"Wang","year":"2016","journal-title":"Cancer Lett"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.612144\/FULL","article-title":"Hepcidin upregulation in lung cancer: A potential therapeutic target associated with immune infiltration","volume":"12","author":"Fan","year":"2021","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12046","article-title":"Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage","volume":"5","author":"Chen","year":"2014","journal-title":"Thorac Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2021.04.034","article-title":"The kidney hepcidin\/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload","volume":"100","author":"Mohammad","year":"2021","journal-title":"Kidney Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-70","article-title":"Tubular reabsorption and local production of urine hepcidin-25","volume":"14","author":"Peters","year":"2013","journal-title":"BMC Nephrol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015040461","article-title":"Renal handling of circulating and renal-synthesized hepcidin and its protective effects against hemoglobin-mediated kidney injury","volume":"27","author":"Van Swelm","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1677\/JOE.1.05729","article-title":"The iron-regulatory peptide hormone hepcidin: Expression and cellular localization in the mammalian kidney","volume":"184","author":"Kulaksiz","year":"2005","journal-title":"J Endocrinol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/BIOF.1468","article-title":"Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology","volume":"45","author":"Vela","year":"2019","journal-title":"BioFactors"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03530509","article-title":"Biomarkers for lupus nephritis: The quest continues","volume":"4","author":"Rovin","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAGEN.2010.08.005","article-title":"Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines","volume":"1800","author":"Zhang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014101037","article-title":"Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis","volume":"26","author":"Scindia","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/S41419-018-0568-Z","article-title":"Endogenous hepcidin synthesis protects the distal nephron against hemin and hemoglobin mediated necroptosis","volume":"9","author":"Van Swelm","year":"2018","journal-title":"Cell Death Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJPATH.2010.12.005","article-title":"Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis","volume":"178","author":"Dendooven","year":"2011","journal-title":"Am J Pathol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/FGENE.2022.902064","article-title":"A cluster of metabolic-related genes serve as potential prognostic biomarkers for renal cell carcinoma","volume":"13","author":"Huang","year":"2022","journal-title":"Front Genet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-270","article-title":"Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma","volume":"9","author":"Kamai","year":"2009","journal-title":"BMC Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/S12885-019-5278-0","article-title":"Serum hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma","volume":"19","author":"Traeger","year":"2019","journal-title":"BMC Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCELL.2015.09.002","article-title":"Preferential iron trafficking characterizes glioblastoma stem-like cells","volume":"28","author":"Schonberg","year":"2015","journal-title":"Cancer Cell"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e89003","DOI":"10.1371\/JOURNAL.PONE.0089003","article-title":"Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells","volume":"9","author":"McCarthy","year":"2014","journal-title":"PloS One"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2017.00332","article-title":"Hepcidin protects neuron from hemin-mediated injury by reducing iron","volume":"8","author":"Zhou","year":"2017","journal-title":"Front Physiol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/S12035-014-8847-X","article-title":"Hepcidin suppresses brain iron accumulation by downregulating iron transport proteins in iron-overloaded rats","volume":"52","author":"Du","year":"2015","journal-title":"Mol Neurobiol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/GLIA.21166","article-title":"Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase a pathway","volume":"59","author":"Du","year":"2011","journal-title":"Glia"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/J.1751-1097.2009.00664.X","article-title":"Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model","volume":"86","author":"Vald\u00e9s","year":"2010","journal-title":"Photochem Photobiol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1023\/B:NEON.0000024238.21349.37","article-title":"Desferoxamine (DFO)\u2013mediated iron chelation: Rationale for a novel approach to therapy for brain cancer","volume":"67","author":"Dayani","year":"2004","journal-title":"J Neuro-oncology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.11.010","article-title":"Therapeutic potential of hepcidin - the master regulator of iron metabolism","volume":"115","author":"Vyoral","year":"2017","journal-title":"Pharmacol Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3804","article-title":"Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation","volume":"75","author":"Gu","year":"2015","journal-title":"Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/IJC.28254","article-title":"Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer","volume":"133","author":"Tuhkanen","year":"2013","journal-title":"Int J Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/NRD.2016.248","article-title":"Targeting iron metabolism in drug discovery and delivery","volume":"16","author":"Crielaard","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2014.00086","article-title":"Hepcidin antagonists for potential treatments of disorders with hepcidin excess","volume":"5","author":"Poli","year":"2014","journal-title":"Front Pharmacol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/S13045-017-0427-X","article-title":"A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia","volume":"10","author":"Vadhan-Raj","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2013-07-515957","article-title":"Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras\/RAF and nutrient-dependent mTOR signaling","volume":"123","author":"Mleczko-Sanecka","year":"2014","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","article-title":"Heparin: A potent inhibitor of hepcidin expression","volume":"117","author":"Poli","year":"2011","journal-title":"Vitro vivo. Blood"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2013-07-515221","article-title":"Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression","volume":"123","author":"Poli","year":"2014","journal-title":"Vitro vivo. Blood"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2017.182865","article-title":"Phase I study of the heparanase inhibitor roneparstat: An innovative approach for ultiple myeloma therapy","volume":"103","author":"Galli","year":"2018","journal-title":"Haematologica"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.802314","article-title":"Anemia in diffuse large b-cell non-Hodgkin lymphoma: The role of interleukin-6, hepcidin and erythropoietin","volume":"55","author":"Tisi","year":"2014","journal-title":"Leukemia lymphoma"},{"key":"B131","doi-asserted-by":"publisher","first-page":"18016","DOI":"10.1038\/nrdp.2018.16","article-title":"Haemochromatosis","volume":"4","author":"Brissot","year":"2018","journal-title":"Nat Rev Dis Primers"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1141603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T06:11:50Z","timestamp":1676959910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1141603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":131,"alternative-id":["10.3389\/fonc.2023.1141603"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1141603","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"article-number":"1141603"}}